Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project

Daniela Martini, Alice Rosi, Michele Tassotti, Monica Antonini, Margherita Dall'Asta, Letizia Bresciani, Federica Fantuzzi, Valentina Spigoni, Raúl Domínguez-Perles, Donato Angelino, Cristian Ricci, Soledad Del Pozo-Luengo, Pedro Luis Tornel, Francesca Scazzina, Angel Gil-Izquierdo, Alessandra Dei Cas, Furio Brighenti, Riccardo Bonadonna, Daniele Del Rio, Pedro Mena, Daniela Martini, Alice Rosi, Michele Tassotti, Monica Antonini, Margherita Dall'Asta, Letizia Bresciani, Federica Fantuzzi, Valentina Spigoni, Raúl Domínguez-Perles, Donato Angelino, Cristian Ricci, Soledad Del Pozo-Luengo, Pedro Luis Tornel, Francesca Scazzina, Angel Gil-Izquierdo, Alessandra Dei Cas, Furio Brighenti, Riccardo Bonadonna, Daniele Del Rio, Pedro Mena

Abstract

Purpose: Coffee is an important source of bioactive compounds, including caffeine, trigonelline, and phenolic compounds. Several studies have highlighted the preventive effects of coffee consumption on major cardiometabolic (CM) diseases, but the impact of different coffee dosages on markers of CM risk in a real-life setting has not been fully understood. This study aimed to investigate the effect of coffee and cocoa-based confectionery containing coffee consumption on several CM risk factors in healthy subjects.

Methods: In a three-arm, crossover, randomized trial, 21 volunteers were assigned to consume in a random order for 1 month: 1 cup of espresso coffee/day, 3 cups of espresso coffee/day, and 1 cup of espresso coffee plus 2 cocoa-based products containing coffee, twice per day. At the last day of each treatment, blood samples were collected and used for the analysis of inflammatory markers, trimethylamine N-oxide, nitric oxide, blood lipids, and markers of glucose/insulin metabolism. Moreover, anthropometric parameters and blood pressure were measured. Finally, food consumption during the interventions was monitored.

Results: After 1 month, energy intake did not change among treatments, while significant differences were observed in the intake of saturated fatty acids, sugars, and total carbohydrates. No significant effect on CM markers was observed following neither the consumption of different coffee dosages nor after cocoa-based products containing coffee.

Conclusions: The daily consumption of common dosages of coffee and its substitution with cocoa-based products containing coffee showed no effect on CM risk factors in healthy subjects.

Trial registration number: Registered at clinicaltrials.gov as NCT03166540, May 21, 2017.

Keywords: Cardiometabolic health; Coffee; Dietary pattern; Randomized-controlled trial; Real-life setting.

Conflict of interest statement

DDR has received research grants from Soremartec. The other authors declare no conflict of interest.

References

    1. Preedy V. Coffee in health and disease prevention. 1. London: Academic Press Inc.; 2015.
    1. Ludwig IA, Mena P, Calani L, et al. Variations in caffeine and chlorogenic acid contents of coffees: what are we drinking? Food Funct. 2014;5:1718–1726. doi: 10.1039/c4fo00290c.
    1. De Peña MP, Ludwig IA, Cid C. Coffee. UK: Royal Society of Chemistry; 2019. Chapter 10. Beverage preparation; pp. 272–291.
    1. Ding M, Bhupathiraju SN, Chen M, et al. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. 2014;37:569–586. doi: 10.2337/dc13-1203.
    1. Shang F, Li X, Jiang X. Coffee consumption and risk of the metabolic syndrome: a meta-analysis. Diabetes Metab. 2016;42:80–87. doi: 10.1016/j.diabet.2015.09.001.
    1. Grosso G, Godos J, Galvano F, Giovannucci EL. Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr. 2017;37:131–156. doi: 10.1146/annurev-nutr-071816-064941.
    1. Arion WJ, Canfield WK, Ramos FC, et al. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys. 1997;339:315–322. doi: 10.1006/abbi.1996.9874.
    1. Ong KW, Hsu A, Tan BKH. Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation. Biochem Pharmacol. 2013;85:1341–1351. doi: 10.1016/j.bcp.2013.02.008.
    1. Yoshinari O, Takenake A, Igarashi K. Trigonelline ameliorates oxidative stress in type 2 diabetic goto-kakizaki rats. J Med Food. 2013;16:34–41. doi: 10.1089/jmf.2012.2311.
    1. Karthikesan K, Pari L, Menon VP. Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents. Chem Biol Interact. 2010;188:643–650. doi: 10.1016/j.cbi.2010.07.026.
    1. Steffen M, Kuhle C, Hensrud D, et al. The effect of coffee consumption on blood pressure and the development of hypertension. J Hypertens. 2012;30:2245–2254. doi: 10.1097/HJH.0b013e3283588d73.
    1. Shaposhnikov S, Hatzold T, El YN, et al. Coffee and oxidative stress: a human intervention study. Eur J Nutr. 2018;57:533–544. doi: 10.1007/s00394-016-1336-4.
    1. Veronese N, Demurtas J, Celotto S, et al. Is chocolate consumption associated with health outcomes? An umbrella review of systematic reviews and meta-analyses. Clin Nutr. 2019 doi: 10.1016/j.clnu.2018.05.019.
    1. Hooper L, Kay C, Abdelhamid A, et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 2012 doi: 10.3945/ajcn.111.023457.
    1. Angelino D, Tassotti M, Brighenti F, et al. Niacin, alkaloids and (poly)phenolic compounds in the most widespread Italian capsule-brewed coffees. Sci Rep. 2018;8:1–11. doi: 10.1038/s41598-018-36291-6.
    1. Mena P, Tassotti M, Martini D, et al. The Pocket-4-Life project, bioavailability and beneficial properties of the bioactive compounds of espresso coffee and cocoa-based confectionery containing coffee: study protocol for a randomized cross-over trial. Trials. 2017;18:1–11. doi: 10.1186/s13063-017-2271-2.
    1. Turconi G, Roggi C (2007) Atlante Fotografico Alimentare: Uno strumento per le indagini nutrizionali. Edizioni Mediche Scientifiche Internazionali, Rome, Italy
    1. Gnagnarella P, Salvini S, Parpinel M (2015) Food composition database for epidemiological studies in Italy. Version 1.2015
    1. Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab. 2003;17:305–322. doi: 10.1016/s1521-690x(03)00042-3.
    1. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi: 10.1007/BF00280883.
    1. Miller CA, Corbin KD, Da Costa KA, et al. Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study. Am J Clin Nutr. 2014 doi: 10.3945/ajcn.114.087692.
    1. Corrêa TAF, Rogero MM, Mioto BM, et al. Paper-filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: a clinical trial. Nutrition. 2013;29:977–981. doi: 10.1016/j.nut.2013.01.003.
    1. MacKenzie T, Comi R, Sluss P, et al. Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial. Metabolism. 2007;56:1694–1698. doi: 10.1016/j.metabol.2007.07.013.
    1. Rosmarin PC, Applegate WB, Somes GW. Coffee consumption and serum lipids: a randomized, crossover clinical trial. Am J Med. 1990;88:349–356. doi: 10.1016/0002-9343(90)90488-Y.
    1. Senn S. Cross-over trials in clinical research. 2. Hoboken: Wiley; 2002.
    1. Poole R, Kennedy OJ, Roderick P, et al. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017 doi: 10.1136/bmj.j5024.
    1. Martini D, Chiavaroli L, González-Sarrías A, et al. Impact of foods and dietary supplements containing hydroxycinnamic acids on cardiometabolic biomarkers: a systematic review to explore inter-individual variability. Nutrients. 2019;11:1805. doi: 10.3390/nu11081805.
    1. Martínez-López S, Sarriá B, Mateos R, Bravo-Clemente L. Moderate consumption of a soluble green/roasted coffee rich in caffeoylquinic acids reduces cardiovascular risk markers: results from a randomized, cross-over, controlled trial in healthy and hypercholesterolemic subjects. Eur J Nutr. 2019;58:865–878. doi: 10.1007/s00394-018-1726-x.
    1. Sarriá B, Martínez-López S, Sierra-Cinos JL, et al. Regularly consuming a green/roasted coffee blend reduces the risk of metabolic syndrome. Eur J Nutr. 2018;57:269–278. doi: 10.1007/s00394-016-1316-8.
    1. Manach C, Milenkovic D, Van de Wiele T, et al. Addressing the inter-individual variation in response to consumption of plant food bioactives: towards a better understanding of their role in healthy aging and cardiometabolic risk reduction. Mol Nutr Food Res. 2017;61:1600557. doi: 10.1002/mnfr.201600557.
    1. Milenkovic D, Morand C, Cassidy A, et al. Interindividual variability in biomarkers of cardiometabolic health after consumption of major plant-food bioactive compounds and the determinants involved. Adv Nutr. 2017;8:558–570. doi: 10.3945/an.116.013623.
    1. Bento-Silva A, Koistinen VM, Mena P, et al. Factors affecting intake, metabolism and health benefits of phenolic acids: do we understand individual variability? Eur J Nutr. 2019 doi: 10.1007/s00394-019-01987-6.10.1007/s00394-019-01987-6.
    1. Turck D, Bresson J, Burlingame B, et al. Guidance for the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health. EFSA J. 2018 doi: 10.2903/j.efsa.2018.5136.
    1. Leclercq C, Arcella D, Piccinelli R, et al. The Italian national food consumption survey INRAN-SCAI 2005–06: main results: in terms of food consumption. Public Health Nutr. 2009;12:2504–2532. doi: 10.1017/S1368980009005035.
    1. Mena P, Del Rio D. Gold standards for realistic (poly)phenol research. J Agric Food Chem. 2018;66:8221–8223. doi: 10.1021/acs.jafc.8b03249.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅